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Mcl-1 is a member of the Bcl2-related protein family that is a critical mediator of cell survival. Exposure of
cells to stress causes inhibition of Mcl-1 mRNA translation and rapid destruction of Mcl-1 protein by
proteasomal degradation mediated by a phosphodegron created by glycogen synthase kinase 3 (GSK3) phos-
phorylation of Mcl-1. Here we demonstrate that prior phosphorylation of Mcl-1 by the c-Jun N-terminal
protein kinase (JNK) is essential for Mcl-1 phosphorylation by GSK3. Stress-induced Mcl-1 degradation
therefore requires the coordinated activity of JNK and GSK3. Together, these data establish that Mcl-1
functions as a site of signal integration between the proapoptotic activity of JNK and the prosurvival activity
of the AKT pathway that inhibits GSK3.
Mcl-1 is an antiapoptotic member of the Bcl2 family. Gene
knockout studies of mice demonstrate that Mcl-1 is essential
for embryonic development and for the survival of hematopoi-
etic cells (28–30). Studies of the stress response have demon-
strated that Mcl-1 plays an important role in the sensitization
of cells to apoptotic signals (1, 11, 25). Thus, exposure to UV
radiation causes the rapid degradation of Mcl-1 and the release
of proapoptotic partner proteins from Mcl-1 complexes (e.g.,
Bim). The mechanism of rapid Mcl-1 destruction is mediated
by the combined actions of two different pathways. First, the
exposure to stress causes phosphorylation of the alpha subunit
of eukaryotic initiation factor 2 (eIF-2) on the inhibitory site
Ser-51 that prevents translation of Mcl-1 mRNA (1, 11, 25).
Second, Mcl-1 is rapidly degraded by the ubiquitin-dependent
proteasome pathway (27). Together, these pathways cause a
rapid reduction in Mcl-1 expression. This loss of Mcl-1 may be
a required initial response for the apoptosis of cells exposed to
stress (25).
The E3 ubiquitin protein ligase Mule/ARF-BP1 contains a
BH3 domain that interacts with Mcl-1 and can initiate ubiq-
uitin-dependent degradation of Mcl-1 (39). Recent studies
have demonstrated that rapid stress-induced degradation of
Mcl-1 is mediated by an alternative pathway involving the E3
ubiquitin protein ligase -TrCP, which binds a stress-induced
phosphodegron created by the phosphorylation of Mcl-1 by
glycogen synthase kinase 3 (GSK3) (7, 21). How the exposure
to stress causes GSK3-mediated phosphorylation of Mcl-1 is
unclear, but GSK3 has been shown to directly phosphorylate
Mcl-1 (7, 21). Mcl-1 phosphorylation and degradation may
therefore be controlled by the prosurvival AKT pathway, which
can negatively regulate GSK3 (7, 21).
Mcl-1 is critically involved in the regulation of cell survival
and is therefore subject to regulation by multiple mechanisms
(26). Thus, Mcl-1 gene expression is regulated by many growth
factors and cytokines (26), and Mcl-1 mRNA is regulated by
microRNA pathways (24). The Mcl-1 protein is stabilized by
binding TCTP (20) and the BH3-only protein Bim (4). In
contrast, the BH3-only protein Noxa binds and destabilizes
Mcl-1 (4, 36). Moreover, it is established that Mcl-1 is phos-
phorylated by several protein kinases on sites that may regulate
Mcl-1 function. Phosphorylation of human Mcl-1 (hMcl-1) on
Ser-64 (a site that is not conserved in other species) may
enhance antiapoptotic activity by increasing the interaction of
Mcl-1 with Bim, Noxa, and Bak (18). Phosphorylation on Ser-
121 and Thr-163 may inhibit the antiapoptotic activity of
hMcl-1 (15), and phosphorylation on Thr-163 may increase
hMcl-1 protein stability (9). The conserved GSK3 phosphory-
lation site Ser-159 (and possibly Ser-155) can initiate rapid
proteasomal degradation of hMcl-1 (7, 21). Together, these
findings suggest that the function of Mcl-1 is very tightly reg-
ulated.
The results of previous studies have implicated the c-Jun
N-terminal protein kinase (JNK) in the regulation of Mcl-1
(15, 18). The purpose of this study was to test whether Mcl-1 is
a target of signal transduction by JNK. We demonstrate that a
key function of JNK is to prime Mcl-1 for phosphorylation by
GSK3. JNK is required for GSK3-mediated degradation of
Mcl-1 in response to stress. Coordinated regulation of the
stress-activated JNK pathway and the AKT-inhibited GSK3
pathway is therefore required for stress-induced Mcl-1 degra-
dation.
MATERIALS AND METHODS
Reagents. The proteasome inhibitor MG132, the JNK inhibitor TAT-JBD,
and 1NM-PP1 were purchased from Calbiochem. Active recombinant GSK3
was obtained from Cell Signaling. The caspase inhibitor zVAD.fmk was obtained
from R&D Systems. Bacterially expressed GST fusion proteins were purified by
affinity chromatography using glutathione-Sepharose 4B (Pharmacia).
Mice. Mice with disruptions of the Jnk1 or Jnk2 gene (10, 38) or a knock-in
mutation in the Jnk2 gene (Jnk2MG) (16) have been described previously. B6;
129X1-Mcl1tm3Sjk/J mice with a floxed Mcl-1 (Mcl-1LoxP) allele (29) and
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Gt(ROSA)26Sortm1(cre/Esr1)Nat/J mice that express a 4-hydroxytamoxifen-induc-
ible Cre recombinase (2) were obtained from The Jackson Laboratory and
backcrossed to the C57BL/6J strain.
Cell culture. We have previously described wild-type, Jnk1/ Jnk2/ (17),
and Jnk1/ Jnk2MG/MG primary murine fibroblasts (16). We also prepared
E13.5 primary murine fibroblasts from Mcl-1LoxP/LoxP Gt(ROSA)26Sor-CreEsr1
mice. COS7 cells were obtained from the American Type Culture Collection.
These cells were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum, 100 units/ml penicillin, 100 g/ml streptomycin,
and 2 mM L-glutamine (Invitrogen). Some cultures were treated with 4-hy-
droxytamoxifen (5). Transfection assays were performed using plasmid expres-
sion vectors and the Lipofectamine reagent (Invitrogen), and cells were har-
vested at 48 h posttransfection. Retroviral transduction of murine fibroblasts was
performed using methods described previously (19).
Plasmids. The mammalian expression vectors for human Mcl-1 (pcDNA3.1-
hMcl-1 [wild type and Ser-159Ala]) were provided by Ulrich Maurer (21). We
constructed the Thr-163Ala point mutation using the QuikChange mutagenesis
kit (Stratagene) using pcDNA3.1-hMcl-1 (wild type) as a template and the
primers T163A S (5-CGG GTC ACT ACC CTC GGC GCC GCC GCC AGC-
3) and T163A AS (5-GCT GGC GGC GGC GCC GAG GGT AGT GAC
CCG-3). The three hMcl1 cDNAs (wild type, Ser-159Ala, and Thr-163Ala) were
also blunt-end cloned into the SalI site of the retroviral expression vector
pBABE-IRES-Puro for transduction assays.
A bacterial expression vector (pGEX4T-1-mMcl-1) and a mammalian expres-
sion vector (pCDNA3-Flag-mMcl-1) for mouse Mcl-1 were provided by Hsin-
Fang Yang-Yen (20). The Thr-144Ala, Thr-144Asp, and Ser-140Ala mutants
were created using the primers T144A S (5-GGC TCT CTG CCC AGC GCT
CCG CCG CCG CCC G-3) and T144A AS (5-CGG GCG GCG GCG GAG
CGC TGG GCA GAG AGC C-3), T144D S (5CGG CTC TCT GCC CTC
GGA TCC GCC GCC GCC CG 3) and T144D AS (5CGG GCG GCG GCG
GAT CCG AGG GCA GAG AGC CG 3), S140A S (5-CCG GGG CCG ACG
GGG CCC TGC CCT CCA CGC CGC CG-3) and S140A AS (5-CGG CGG
CGT GGA GGG CAG GGC CCC CGT CGG CCC CGG-3). The wild-type
and mutant mMcl-1 cDNAs were also blunt-end cloned into the SalI site of the
retroviral expression vector pBABE-IRES-Puro for transduction assays.
Expression vectors for wild-type and K85A mutant HA-GSK3 (12) were
obtained from Addgene (Addgene plasmids 14753 and 14755). The bacterial
expression vector for GST-Bcl3 was provided by Alain Chariot (32).
Immunoblot analysis. Immunoblot analysis was performed using antibodies
to AKT and phospho-Ser473 AKT (Cell Signaling), GSK3 and phospho-Ser-
9/21 GSK3/ (Cell Signaling), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Santa Cruz), hMcl-1 (Pharmingen), mMcl-1 (Rockland), and -tu-
bulin (Covance). The pSer159 hMcl-1 antibody was provided by Ulrich Maurer
(21). Immune complexes were detected using enhanced chemiluminescence with
X-ray film or a Kodak 4000MM imaging station.
Mass spectroscopy. Mcl-1 isolated by immunoprecipitation was examined af-
ter sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by
staining with Brilliant Blue G Colloidal. The Mcl-1 gel band was excised and
processed for digestion with trypsin (Promega; 12.5 ng/l in 50 mM ammonium
bicarbonate, pH 8.9) or Glu-C (Sigma-Aldrich; 125 ng/l in 100 mM ammonium
bicarbonate, pH 7.8) (3). Phosphopeptides were purified using an IMAC column
and eluted onto a column packed with C18 beads (23). The column was placed
in-line with a tapered electrospray column packed with C18 beads on a QStar XL
or QStar Elite mass spectrometer (Applied Biosystems). Peptides were eluted
using a 20-min gradient (0 to 70% acetonitrile in 0.2 M acetic acid; 50 nl/min).
Data were collected using the mass spectrometer in data-dependent acquisition
mode to collect tandem mass spectra and examined using Mascot software
(Matrix Science). Mass spectra matching phosphorylated peptides derived from
Mcl-1 were examined manually to identify phosphorylation sites and fragmen-
tation ions.
In vitro kinase assays. Protein kinase assays using [-32P]ATP and protein
(glutathione S-transferase [GST]-ATF2, GST-Bcl-3, GST-c-Jun, GST-Elk-1, and
GST-mMcl-1) substrates were performed using standard methods with immu-
nopurified epitope-tagged mitogen-activated protein (MAP) kinases and GSK3
isolated from transiently transfected COS7 cells (35). The phosphorylation re-
action was terminated after 30 min at 30°C by the addition of Laemmli sample
buffer, and the phosphorylated proteins were examined by SDS-PAGE and
phosphorimager analysis.
Two-step kinase assays were performed to examine the effect of prior phos-
phorylation of GST-Mcl-1 by JNK on the subsequent phosphorylation of GST-
mMcl-1 by GSK3. We transiently expressed Flag-JNK1 in COS7 cells. Lysates
were prepared using Triton lysis buffer (20 mM Tris [pH 7.4], 137 mM NaCl, 2
mM EDTA, 1% Triton X-100, 10% glycerol, 25 mM -glycerophosphate, 1 mM
sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and
10 g/ml aprotinin). The Flag-JNK1 was immunoprecipitated using 1 g M2
monoclonal antibody (Sigma) immobilized on 10 l of protein G-Sepharose
(Pharmacia) and washed three times with Triton lysis buffer and twice with
kinase buffer (25 mM HEPES [pH 7.4], 25 mM -glycerophosphate, 25 mM
MgCl2, 2 mM dithiothreitol, and 0.1 mM sodium vanadate). Kinase assays were
performed using 5 M GST-Mcl-1 and 1 mM ATP (30 min at 30°C). Some
first-step kinase assays were performed using 5 M JNK inhibitor (TAT-JBD).
The supernatant was collected, and the GST-Mcl-1 was isolated using 10 l
glutathione-Sepharose 4B (Pharmacia) at 4°C (1 h) and then washed twice with
kinase buffer. The second-step protein kinase assay was then performed (30 min
at 30°C) by addition of active GSK3 (500 U; Cell Signaling) and 50 M
[-32P]ATP (10 Ci/mmol). Phosphorylated GST-Mcl-1 was examined by SDS-
PAGE, autoradiography, and phosphorimager analysis.
Apoptosis assays. Cell death was examined by measurement of DNA frag-
mentation using the Cell Death Detection Elisaplus kit (Roche) according to the
manufacturer’s recommendations (19).
Colony assays. Fibroblasts were exposed to UV radiation (60 J/m2) and cul-
tured for 16 h. These cells were replated (2  105 cells/100-mm dish), incubated
for 14 days, fixed in methanol, and stained with 0.5% crystal violet.
RESULTS
JNK is required for rapid UV-stimulated degradation of
Mcl-1. Mcl-1 is a short-lived protein that is degraded by the
ubiquitin-mediated proteasome pathway (27). Indeed, the
Mcl-1 protein is rapidly eliminated from cells exposed to stress,
in part because of translational inhibition caused by phosphor-
ylation of eIF-2 on the inhibitory site Ser-51 (1, 11, 25). This
exposure to stress also causes activation of the JNK signal
transduction pathway (6). To test whether JNK may play a role
in the rapid degradation of Mcl-1 in cells exposed to stress, we
examined the effect of UV radiation on Mcl-1 degradation in
wild-type and Jnk1/ Jnk2/ fibroblasts. The JNK-deficient
fibroblasts were found to exhibit reduced Mcl-1 degradation
(Fig. 1A). Indeed, the half-life of Mcl-1 in wild-type fibroblasts
(34 	 6.2 min) was significantly shorter than that in JNK-
deficient fibroblasts (121 	 11 min) following exposure to UV
radiation (mean 	 standard deviation [SD]; n 
 6; P 
0.0005). This observation suggested that JNK may contribute
to Mcl-1 degradation. To confirm this finding, we employed a
chemical genetic approach using fibroblasts isolated from mice
with a germ line point mutation that confers sensitivity of JNK
to inhibition by the drug 1NM-PP1 (16). This analysis demon-
strated that JNK inhibition markedly decreased UV-stimu-
lated degradation of Mcl-1 (Fig. 1B). We conclude the JNK
activity is required for the rapid degradation of Mcl-1 caused
by exposure of cells to stress.
It is established that Mcl-1 degradation can be mediated by
at least two different pathways mediated by caspases (13, 22)
and the proteasome (27). To test the requirement of caspases
for Mcl-1 degradation, we examined the effect of treatment of
cells with the broad-spectrum caspase inhibitor zVAD-fmk; no
significant effect of caspase inhibition on Mcl-1 degradation
was detected (Fig. 1C). In contrast, inhibition of the protea-
some with the drug MG132 blocked the effect of UV radiation
to decrease Mcl-1 expression (Fig. 1D). Together, these data
demonstrate that UV-induced Mcl-1 degradation is mediated
by the proteasome pathway.
JNK is required for Mcl-1 degradation caused by inhibition
of AKT. It is established that serum withdrawal causes degra-
dation of Mcl-1 by an AKT/GSK3-dependent signaling path-
way (7, 21). This mechanism of Mcl-1 degradation may be JNK
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independent. To test this hypothesis, we examined Mcl-1
expression in wild-type and Jnk1/ Jnk2/ fibroblasts. Se-
rum withdrawal caused inhibition of AKT and decreased
inhibitory phosphorylation of GSK3 in both wild-type and
JNK-deficient fibroblasts (Fig. 1E). These changes were as-
sociated with loss of Mcl-1 protein expression in wild-type
fibroblasts. However, serum withdrawal did not cause loss of
Mcl-1 in JNK-deficient fibroblasts (Fig. 1E). Together, these
data indicate that JNK is required for Mcl-1 degradation
caused by the AKT/GSK3 pathway. This observation sug-
gests cooperation between the JNK and AKT/GSK3 signal-
ing pathways in the regulation of Mcl-1. This cooperative
mechanism may be relevant not only to serum withdrawal
but to Mcl-1 regulation by other forms of cell stress. Indeed,
we found that UV radiation caused the activation of both
JNK and GSK3 (Fig. 1F).
FIG. 1. JNK is required for stress-induced degradation of Mcl-1. (A) Wild-type (WT) and Jnk1/ Jnk2/ fibroblasts were exposed to UV
radiation (60 J/m2). Lysates prepared from these cells at different times postirradiation were examined by immunoblot analysis by probing with
antibodies to Mcl-1 and -tubulin. The amounts of Mcl-1 and -tubulin were quantitated using a Kodak 4000MM imaging station. The half-life
of Mcl-1 in wild-type fibroblasts (34	 6.2 min) was significantly greater (P 0.0005) than that in JNK-deficient fibroblasts (121	 11 min) (mean	
SD; n 
 6). (B) Jnk1/ Jnk2MG/MG fibroblasts were incubated without and with 10 M 1NM-PP1 and exposed to UV radiation (60 J/m2), and
the expression of Mcl-1 and -tubulin was examined by immunoblot analysis. (C) Wild-type fibroblasts were incubated without and with the caspase
inhibitor zVAD.fmk (20 M) for 60 min and then exposed to UV radiation (60 J/m2). The amounts of Mcl-1 and -tubulin at different times
postirradiation were examined by immunoblot analysis. (D) Wild-type fibroblasts were incubated without and with the proteasome inhibitor
MG132 (10 M) for 60 min and then exposed to UV radiation (60 J/m2). The amounts of Mcl-1 and -tubulin at different times postirradiation
were examined by immunoblot analysis. (E) Wild-type and Jnk1/ Jnk2/ fibroblasts were transferred to serum-free medium. Lysates prepared
at different times after serum withdrawal were examined by immunoblot analysis by probing with antibodies to Mcl-1, JNK1/2, phospho-Ser9/21-
GSK3/, GSK3, phospho-Ser473-AKT, AKT, and -tubulin. (F) COS7 cells expressing hemagglutinin-tagged GSK3 were exposed to UV
radiation (60 J/m2). Cell lysates were prepared at 40 min postirradiation and examined by immunoblot analysis using antibodies to GSK3 and
GAPDH. Studies were performed using wild-type and kinase-inactive (K85A) GSK3. JNK and GSK3 activities were measured in an immune
complex kinase assay with [-32P]ATP using the protein substrates GST-cJun and GST-Bcl3, respectively. GST-Bcl3 and GST-cJun were stained
after SDS-PAGE with Coomassie blue, and the phosphorylated proteins were detected by autoradiography.
VOL. 29, 2009 Mcl-1 IS TARGETED BY JNK AND GSK3 3847
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Mcl-1 is a JNK substrate. JNK phosphorylates human Mcl-1
on Ser-64, Ser-121, and Thr-163 (15, 18). We examined the
phosphorylation of mouse Mcl-1 (mMcl-1) by MAP kinases in
vitro (Fig. 2). mMcl-1 was phosphorylated by JNK, but little
phosphorylation of mMcl-1 by extracellular signal-regulated
kinase (ERK) or p38 MAP kinase was detected. Ser-64 of
hMcl-1 is not conserved in the mouse (it is replaced by Glu)
and is therefore not a potential mMcl-1 phosphorylation site.
However, both Ser-121 and Thr-163 of hMcl-1 are conserved
in mMcl-1. Mutagenesis studies demonstrated that the site
corresponding to Thr-163 of hMcl-1 (Thr-144) was the major
site of mMcl-1 phosphorylation by JNK, because replacement
of Thr-144 with Ala strongly suppressed JNK-mediated
phosphorylation of mMcl-1. Control studies demonstrated
that mutation of mMcl-1 at Ser-140 caused no defect in
JNK-mediated phosphorylation of mMcl-1 (Fig. 2A). To-
gether, these data demonstrate that mMcl-1 is phosphory-
lated on Thr-144 by JNK.
JNK primes Mcl-1 for phosphorylation by GSK3. It has
been reported that GSK3 can phosphorylate hMcl-1 on Ser-
159 (21). This site of phosphorylation is conserved in mMcl-1
(Ser-140). However, we found that GSK3 was unable to phos-
phorylate mMcl-1 in an in vitro kinase assay (Fig. 3A). Priming
phosphorylation of the substrate is often required prior to
recognition by the GSK3 protein kinase (8). Consensus se-
quence analysis (Ser/Thr-X-X-X-phospho-Ser/Thr) indicated
that the residue on Mcl-1 identified as the major phosphory-
lation site for JNK (Fig. 2) may act as the priming site for
Mcl-1 phosphorylation by GSK3 (8). To test this hypothesis,
we examined Mcl-1 using a two-step in vitro kinase assay (Fig.
3A). This analysis demonstrated that GSK3 phosphorylated
Mcl-1 only after prior phosphorylation of Mcl-1 by JNK. In-
deed, GSK3 phosphorylation of Mcl-1 was blocked by the
absence of JNK, the presence of a JNK inhibitor, or the ab-
sence of ATP in the priming phosphorylation reaction (Fig.
3A). These observations suggested that JNK may serve as a
kinase that primes mMcl-1 for phosphorylation by GSK3.
It is established that some GSK3 substrates are phosphory-
lated in the absence of priming phosphorylation (8). Indeed, it
has been reported that priming may not be required for phos-
phorylation of Mcl-1 by GSK3 (7). To test whether the JNK-
mediated priming site (Thr-144) was required for GSK3 phos-
phorylation of mMcl-1 on Ser-140, we examined the effect of
replacing these phosphorylation sites with Ala using the two-
step in vitro kinase assay (Fig. 3B). This analysis demonstrated
that GSK3 phosphorylated mMcl-1 only after prior phosphor-
ylation by activated JNK and that this GSK3-mediated phos-
phorylation required both the JNK-mediated priming site
(Thr-144) and the GSK3 phosphorylation site (Ser-140) on
mMcl-1 (Fig. 3B). Both of these phosphorylation sites are
located within the phosphodegron motif (DGpS140LPSpT144)
of Mcl-1 (7, 21).
Mutational analysis of Mcl-1 phosphorylation in vivo. In
vitro studies demonstrate that phosphorylation on the JNK site
acts to prime Mcl-1 for phosphorylation by GSK3 (Fig. 3A). To
test the biological relevance of this finding, we examined the in
vivo phosphorylation of the mMcl-1 phosphodegron motif by
mass spectroscopy (Fig. 3D to F). Studies of wild-type mMcl-1
demonstrated dual phosphorylation of the phosphodegron mo-
tif (DGpS140LPSpT144) on Ser-140 plus Thr-144 (Fig. 3D). The
phosphodegron motif was also phosphorylated on Thr-144
alone. In contrast, no phosphorylation of the phosphodegron
motif on Ser-140 alone was detected. Together, these data
indicate that Thr-144 may act as a priming site for mMcl-1
phosphorylation on Ser-140 in vivo. This conclusion is consis-
tent with the finding that Ser-140Ala mMcl-1 was phosphory-
lated on Thr-144 (Fig. 3D). In contrast, no phosphorylation of
the phosphodegron motif of Thr-144Ala mMcl-1 was detected
(Fig. 3D).
To obtain independent evidence that the priming phosphor-
ylation site was required for GSK3-mediated phosphorylation
of Mcl-1 in vivo, we examined the phosphorylation of Mcl-1 by
immunoblot analysis using an antibody to phospho-hMcl-1 that
specifically recognizes the GSK3 phosphorylation site. As ex-
pected, replacement of the Ser residue that is phosphorylated
by GSK3 with Ala prevented detection of Mcl-1 by immuno-
blot analysis (Fig. 3C). This analysis confirmed the specificity
of the phospho-Mcl-1 antibody. Mutation of the JNK phos-
phorylation site that primes Mcl-1 for phosphorylation by
GSK3 in vitro (Fig. 3A and B) also prevented the phosphory-
lation of Mcl-1 on the GSK3 site in vivo (Fig. 3C). Together,
these data demonstrate that Mcl-1 is a conditional substrate
for GSK3 that requires priming phosphorylation on the JNK
site in vivo.
Phosphorylation is required for UV-stimulated Mcl-1 deg-
radation. Exposure of fibroblasts to UV radiation causes rapid
degradation of mMcl-1. To test whether mMcl-1 phosphoryla-
tion is required, we compared the UV-stimulated degradation
of wild-type and phosphorylation-defective mMcl-1 proteins
FIG. 2. Mcl-1 is a JNK substrate in vitro. (A) MAP kinases (JNK,
p38, and ERK2) were immunopurified from COS cells exposed to
UV radiation or 10% fetal bovine serum. Protein kinase assays were
performed using 50 M [-32P]ATP (10 Ci/mmol) and GST-mMcl-1.
The effect of replacement of Thr-144 or Ser-140 with Ala was exam-
ined. (B) Control assays were performed using JNK1, p38 MAP
kinase, and ERK2 and the substrates GST-cJun, GST-ATF2, and
GST-Elk-1, respectively.
3848 MOREL ET AL. MOL. CELL. BIOL.
 o
n
 August 25, 2016 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
(Fig. 4). The half-life of wild-type Mcl-1 was significantly
shorter than that of the phosphorylation-defective mMcl-1
proteins (Thr-144Ala and Ser-140Ala). These data confirm
that both the JNK phosphorylation site (Thr-144) that primes
Mcl-1 for phosphorylation by GSK3 and the GSK3 phosphor-
ylation site Ser-140 are required for UV-stimulated Mcl-1 deg-
radation.
A phosphomimetic mutation (Thr-144Asp) that results in
FIG. 3. JNK primes Mcl-1 for phosphorylation by GSK3. (A) Upper panel, schematic illustration of the in vitro kinase assay. GST-mMcl-1 was
incubated (30 min at 30°C) in step 1 without and with 1 mM ATP, JNK1, UV-activated JNK1, and/or the JNK inhibitor (JNKi) TAT-JBD (30-l
final volume). The GST-mMcl-1 was bound to glutathione-agarose beads, washed, and then incubated (30 min at 30°C) in step 2 with 500 units
of GSK3 plus 50 M [-32P]ATP (10 Ci/mmol) (30-l final volume). The products of the phosphorylation reaction were examined by
SDS-PAGE and autoradiography. Lower panel, the two-step in vitro kinase assay was performed using wild-type Mcl-1 as the substrate. The effect
of changes in step 1 of the kinase reaction (addition of ATP, JNK, UV-activated JNK, and/or JNK inhibitor [JNKi] TAT-JBD) was examined.
(B) The two-step in vitro kinase assay was performed using mMcl-1 as the substrate. The effect of replacement of the JNK phosphorylation site
(Thr) or the GSK3 phosphorylation site (Ser) with Ala was examined (T/A and S/A). Step 1 of the in vitro kinase assay was performed using JNK
or UV-activated JNK. WT, wild type. (C) COS cells were transiently transfected without or with an expression vector for hMcl-1. The effect of
replacement of the JNK phosphorylation site (Thr) or the GSK3 phosphorylation site (Ser) with Ala was examined (T/A and S/A). Phosphorylation
of hMcl-1 on the GSK3 phosphorylation site in vivo was examined by immunoblot analysis using antibodies to phosphoSer159-hMcl-1 and hMcl-1.
(D) COS7 cells expressing hemagglutinin-tagged mMcl-1 were treated with the proteasome inhibitor MG132 (10 M) and incubated (60 min). The
cells were then exposed to 60 J/m2 UV radiation. Protein extracts were prepared at 40 min postirradiation. The mMcl-1 protein was isolated by
immunoprecipitation and SDS-PAGE. mMcl-1 peptides obtained after digestion with trypsin or Glu-C were examined by mass spectroscopy.
Peptides corresponding to the phosphodegron motif were identified. The detection of phosphorylation at a single site (pSer or pThr) or dual
phosphorylation (pThr pSer) is summarized. The effect of replacement of Thr-144 and Ser-140 with Ala is shown. (, phosphopeptide detected;
, phosphopeptide not detected). (E and F) Representative spectra of phosphopeptides obtained after digestion of wild-type mMcl-1 with Glu-C.
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negative charge at the priming phosphorylation site also
caused stabilization of mMcl-1 (Fig. 5A). This is most likely
because of a requirement for phosphate at the priming site
(rather than simply a negative charge) for subsequent phos-
phorylation of target proteins by GSK3 (33).
UV-stimulated cell death is suppressed by defects in Mcl-1
phosphorylation. Exposure of cells to stress causes phosphor-
ylation of eIF-2 on Ser-51 and inhibition of Mcl-1 mRNA
translation (1, 11, 25). The subsequent degradation of Mcl-1
contributes to the sensitization of cells to apoptosis (25). This
degradation is mediated by the E3 ubiquitin protein ligase
-TrCP, which recognizes GSK3-phosphorylated Mcl-1 (7). If
JNK phosphorylation of Mcl-1 on the priming site is required
for GSK3 phosphorylation, mutation of Mcl-1 at either the
JNK or GSK3 phosphorylation site would be predicted to
suppress apoptosis by increasing Mcl-1 function. To test this
hypothesis, we examined the effect of mutating these Mcl-1
phosphorylation sites on UV-stimulated apoptosis. We found
that mutation of either the JNK or the GSK3 phosphorylation
site on Mcl-1 (by replacement with Ala) caused similar changes
in UV-stimulated cell death (Fig. 6A). These phosphorylation-
defective Mcl-1 proteins caused reduced UV-stimulated apop-
totic DNA fragmentation compared with that caused by wild-type
Mcl-1 (Fig. 5B and 6A). Similarly, the phosphorylation-defec-
tive Mcl-1 proteins caused increased cell survival after expo-
sure to UV radiation compared with wild-type Mcl-1 in a
colony formation assay (Fig. 6B). Together, these data confirm
that both the JNK and GSK3 phosphorylation sites are re-
quired for downregulation of Mcl-1 antiapoptotic activity and
are consistent with the conclusion that JNK is required for the
rapid GSK3-mediated phosphorylation and degradation of
Mcl-1.
DISCUSSION
The JNKs can mediate proapoptotic signal transduction (6).
The mechanism of JNK-induced apoptosis is unclear, but JNK-
deficient fibroblasts exhibit defects in mitochondrial outer
membrane permeabilization and the release of cytochrome c
(31). JNK substrates that are implicated in apoptosis include
members of the Bcl2-related protein family (34). Thus, mice
with a germ line mutation in the Bim gene at the phosphory-
FIG. 4. Phosphorylation is required for UV-stimulated Mcl-1 deg-
radation. Murine Mcl-1LoxP/LoxP Gt(ROSA)26Sor-CreEsr1 fibroblasts
were transduced with an mMcl-1 (wild type [WT], Thr-144Ala, or
Ser-140Ala) expression vector or an empty pBABE-IRES-Puro vector
(control) and selected by treatment with 2 g/ml puromycin (2 days).
The endogenous Mcl-1 gene was deleted by treatment of the cells with
1 M 4-hydroxytamoxifen (1 day). The half-life of the mMcl-1 protein
was examined following exposure of the cells to UV radiation (60
J/m2). The amounts of Mcl-1 and -tubulin were detected by autora-
diography and quantitated using a Kodak 4000MM imaging station.
The half-lives of wild-type and phosphorylation-defective Mcl-1 pro-
teins (T/A and S/A) are presented. The half-lives of the mutant pro-
teins were significantly longer than that of wild-type Mcl-1 (mean 	
SD; n 
 6; *, P  0.05; **, P  0.01).
FIG. 5. Effect of a phosphomimetic mutation at the JNK phosphor-
ylation site on Mcl-1 protein half-life and apoptotic activity. (A) Mu-
rine Mcl-1LoxP/LoxP Gt(ROSA)26Sor-CreEsr1 fibroblasts were trans-
duced with an mMcl-1 (wild type [WT] or Thr-144Asp) expression
vector or an empty pBABE-IRES-Puro vector (control) and selected
by treatment with 2 g/ml puromycin (2 days). The endogenous Mcl-1
gene was deleted by treatment of the cells with 1 M 4-hydroxytamox-
ifen (1 day). The half-life of the mMcl-1 protein was examined follow-
ing exposure of the cells to UV radiation (60 J/m2). The amounts of
Mcl-1 and -tubulin were detected by autoradiography and quanti-
tated using a Kodak 4000MM imaging station. The half-life of Thr-
144Asp (T/D) mMcl-1 was significantly greater than that of wild-type
Mcl-1 (mean 	 SD; n 
 5; *, P  0.001). (B) Murine fibroblasts were
transduced with an mMcl-1 (WT or Thr-144Asp) expression vector or
an empty retroviral vector (control). Immunoblot analysis indicated
the expression of the wild-type and mutated mMcl-1 proteins (inset).
Cell death was measured by DNA fragmentation 16 h after UV treat-
ment (60 J/m2) and is presented as the mean 	 SD (n 
 5). The
antiapoptotic activity of Thr-144Asp mMcl-1 was significantly greater
than that of wild-type (WT) Mcl-1 (*, P  0.0005).
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lation site Thr-112 (replacement with Ala) exhibit defects in
Bim-dependent apoptosis (14). However, BimEL phosphory-
lation by JNK on Thr-112 is not sufficient, by itself, to fully
account for JNK-induced apoptosis (14). These data suggest
that BimEL may cooperate with another JNK substrate to
mediate JNK-stimulated apoptosis. One candidate substrate is
Mcl-1 (34). Indeed, previous studies have established that the
rapid reduction of Mcl-1 expression detected in cells exposed
to stress may be critical for stress-induced apoptosis (25). The
mechanism of stress-induced reduction in Mcl-1 expression is
mediated by phosphorylation of eIF-2 on the inhibitory site
Ser-51 that prevents translation of Mcl-1 mRNA (1, 11, 25) and
rapid degradation of Mcl-1 protein mediated by the ubiquitin-
dependent proteasome pathway (27).
The E3 ubiquitin protein ligases that mediate degradation of
Mcl-1 include Mule/ARF-BP1 (39) and -TrCP (7). Stress-
induced degradation of Mcl-1 appears to be mediated by a
phosphodegron (DGpSLPSpT) that interacts with -TrCP (7).
Phosphorylation of this phosphodegron motif is mediated by
GSK3 (7, 21). This conclusion is supported by studies of small
interfering RNA-mediated knockdown of GSK3 expression
(21) and by studies of fibroblasts isolated from GSK3 knockout
mice (7). GSK3 is therefore a negative regulator of Mcl-1
expression. Significantly, the prosurvival protein kinase AKT is
a negative regulator of GSK3. Consequently, prosurvival sig-
naling by AKT can increase Mcl-1 expression by inhibiting
GSK3-mediated Mcl-1 degradation (7, 21).
Priming phosphorylation is required for recognition of
Mcl-1 as a substrate by GSK3. Thus, in vitro assays demon-
strate that GSK3 does not phosphorylate Mcl-1 (Fig. 3A).
However, Thr-144 within the phosphodegron motif DGpS140
LPSpT144 can serve to prime Mcl-1 for phosphorylation by
GSK3 on Ser-140 (Fig. 3). Our studies of JNK-deficient cells
demonstrate that JNK represents the major protein kinase
activity that mediates phosphorylation of Mcl-1 on the priming
site (Fig. 1). However, it should be noted that our analysis was
restricted to the response of murine fibroblasts to serum star-
vation and UV radiation. It is possible that other protein ki-
nases may contribute to the priming phosphorylation of Mcl-1
in other cell types or in response to other stimuli.
Dual phosphorylation of the Mcl-1 phosphodegron in re-
sponse to stress in fibroblasts requires activation of both JNK
and GSK3. JNK can be activated by a canonical stress-induced
signaling pathway (6). In contrast, the major control of GSK3
activity is mediated by negative regulation, for example, by
inhibitory phosphorylation by mediated AKT (8). Efficient
dual phosphorylation of the Mcl-1 phosphodegron motif may
therefore be mediated by the coordinated actions of activated
JNK and inhibited AKT signaling pathways. This may provide
a molecular explanation for previous findings that the pro-
apoptotic activity of JNK is suppressed by activation of the
prosurvival AKT signaling pathway (37). Together, these con-
siderations implicate Mcl-1 as a site of signal integration be-
tween proapoptotic (JNK) and prosurvival (e.g., AKT) protein
kinase signaling pathways.
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